Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation

B cell depletion by rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). However, peripheral B cell phenotypes and the selection criteria f...

Source: Arthritis Research and Therapy - June 15, 2020 Category: Rheumatology Authors: Yusuke Miyazaki, Shingo Nakayamada, Satoshi Kubo, Yuichi Ishikawa, Maiko Yoshikawa, Kei Sakata, Shigeru Iwata, Ippei Miyagawa, Kazuhisa Nakano and Yoshiya Tanaka Tags: Research article Source Type: research